Shalby Ltd
NSE:SHALBY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
180.06
266.83
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Shalby Ltd
Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The company offers tertiary and quaternary healthcare services to patients in various areas of specialization, such as orthopedics, complex joint replacements, cardiology, neurology, oncology and renal transplantations, among others. The company provides tertiary and qua-tertiary medical services, including home healthcare and medics/paramedics educational and training programs. The company is also running home healthcare services to deliver medicines, nurses, attendants and other products at home and also running educational and training programs to upgrade and enhance the skills in healthcare industry.
Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The company offers tertiary and quaternary healthcare services to patients in various areas of specialization, such as orthopedics, complex joint replacements, cardiology, neurology, oncology and renal transplantations, among others. The company provides tertiary and qua-tertiary medical services, including home healthcare and medics/paramedics educational and training programs. The company is also running home healthcare services to deliver medicines, nurses, attendants and other products at home and also running educational and training programs to upgrade and enhance the skills in healthcare industry.
Revenue Growth: Shalby Limited reported consolidated Q2 FY26 revenue of INR 289 crore, up 5.5% year-on-year, driven by higher ARPOB despite lower volumes.
Margin Improvement: EBITDA margin improved to 15.9% from 14.5% last year, with PAT margin jumping to 2.5% from 0.9%—a 200% YoY PAT increase.
MedTech Surge: Shalby MedTech saw a 42.1% YoY revenue increase and strong EBITDA turnaround, attributed to robust implant sales and cost reduction.
Shalby International Weakness: Shalby International Hospital reported a sharp revenue decline (down 22.7% YoY) and low 21% occupancy; management expects turnaround in two quarters.
Volume Softness: IP/OP volumes declined due to poor weather, lack of seasonal illnesses, and TPA negotiations, but recovery is expected as new doctors join and TPA deals close.
CapEx and Technology: Significant investments made in robotic and oncology equipment (INR 70 crore in H1), with further capacity and technology enhancements planned.
Payor Mix & Diversification: Payor mix remains healthy and business diversification continues, with ortho now at 34% of revenue—down from historic levels.
